NASDAQ · Financial Statements
Hillstream BioPharma, Inc. (HILS) Financial Statements
$0.24
NASDAQ: HILS
Market Cap $4.17M
Overview Financials Dividend Hillstream BioPharma, Inc. most recently reported annual revenue of $0, net profit of $-36.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-3.0M $-7.0M $-9.0M $-12.0M $-20.0M Net Profit $-3.0M $-8.0M $-9.0M $-12.0M $-36.0M EPS $-0.30 $-0.75 $-7.14 $-9.41 $-1.12 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $1.0M $7.0M $11.0M $4.0M $519.0M Total Liabilities $5.0M $1.0M $2.0M $2.0M $121.0M Cash $0 $7.0M $11.0M $4.0M $17.0M Borrowings $2.0M $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-1.0M $-7.0M $-7.0M $-11.0M $-16.0M Investing Cash Flow $0 $0 $0 $0 $-78.0M Financing Cash Flow $1.0M $13.0M $12.0M $4.0M $107.0M Net Cash Flow $0 $7.0M $4.0M $-7.0M $13.0M Free Cash Flow $-1.0M $-7.0M $-7.0M $-11.0M $-16.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.69 FCF Yield -505.16% Quick Ratio 37.75 Interest Coverage -4634.51 Return 1Y — Return 3Y — Return 5Y —
Screens featuring this stock